Katherine A Janeway Selected Research

Katherine A Janeway Research Topics

Disease

53	Neoplasms (Cancer) 12/2023 - 07/2009
24	Osteosarcoma (Osteogenic Sarcoma) 12/2023 - 07/2010
12	Ewing Sarcoma (Sarcoma, Ewing) 12/2023 - 01/2017
8	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 11/2012
8	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020 - 10/2007
4	Neoplasm Metastasis (Metastasis) 11/2020 - 08/2014
3	Disease Progression 11/2023 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2022 - 04/2011
3	Paraganglioma (Paragangliomas) 11/2021 - 01/2011
2	Brain Neoplasms (Brain Tumor) 11/2023 - 07/2017
2	Lymphoma (Lymphomas) 11/2023 - 10/2022
2	Glioma (Gliomas) 10/2022 - 06/2013
2	Fibrosarcoma 08/2022 - 01/2018
2	Aggressive Fibromatosis (Desmoid) 10/2020 - 07/2017
2	Left Ventricular Dysfunction 01/2019 - 10/2016
1	Pneumothorax 12/2023
1	Myofibromatosis 01/2023
1	Long Term Adverse Effects 12/2022
1	Plexiform Neurofibroma 10/2022
1	Sudden Death 09/2022
1	Soft Tissue Neoplasms 08/2022
1	Glomus Tumor (Glomus Tumors) 01/2022
1	Hypoxia (Hypoxemia) 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Headache (Headaches) 11/2021
1	Polycythemia (Erythrocytosis) 11/2021
1	Leukemia 01/2021
1	Adenocarcinoma 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2020
1	Desmoplastic Small Round Cell Tumor 10/2020
1	Myofibroma 04/2020
1	Medullary Carcinoma 12/2019

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2013
7	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2011
7	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2014
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 07/2016 - 01/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 12/2021
3	Methotrexate (Mexate)FDA LinkGeneric 06/2023 - 07/2010
3	Phosphotransferases (Kinase)IBA 01/2023 - 06/2013
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 07/2010
2	Topotecan (Hycamtin)FDA LinkGeneric 12/2023 - 12/2021
2	Insulin (Novolin)FDA Link 10/2023 - 01/2016
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2023 - 04/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2022 - 01/2016
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2022 - 01/2013
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022 - 10/2020
2	Vincristine (Oncovin)FDA LinkGeneric 12/2021 - 10/2020
2	NucleotidesIBA 01/2021 - 07/2017
2	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 03/2019 - 01/2017
2	Sunitinib (Sutent)FDA Link 01/2019 - 07/2009
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 07/2009
2	Cisplatin (Platino)FDA LinkGeneric 10/2016 - 07/2010
2	Etoposide (VP 16)FDA LinkGeneric 10/2016 - 07/2010
2	Ifosfamide FDA LinkGeneric 10/2016 - 07/2010
2	TOR Serine-Threonine KinasesIBA 01/2016 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2013 - 01/2013
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2009 - 10/2007
1	fludarabineIBA 04/2024
1	Chimeric Antigen ReceptorsIBA 04/2024
1	cabozantinibIBA 12/2023
1	tazemetostatIBA 11/2023
1	Tyrosine Kinase InhibitorsIBA 11/2023
1	ganitumabIBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	Circulating Tumor DNAIBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 10/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	AZD 6244IBA 10/2022
1	dinutuximabIBA 09/2022
1	CytokinesIBA 09/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 08/2022
1	tyrosine receptor (receptor, tyrosine)IBA 08/2022
1	ran-binding protein 2IBA 08/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	morinIBA 11/2021
1	belzutifanIBA 11/2021
1	Investigational DrugsIBA 04/2021
1	ElementsIBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	LigandsIBA 11/2020
1	nirogacestatIBA 10/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2020
1	Temozolomide (Temodar)FDA LinkGeneric 10/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	Ubiquitin-Conjugating EnzymesIBA 12/2019
1	Proteasome InhibitorsIBA 12/2019
1	glembatumumab vedotinIBA 11/2019

Therapy/Procedure

34	Therapeutics 12/2023 - 07/2010
10	Drug Therapy (Chemotherapy) 10/2023 - 07/2010
4	Precision Medicine 01/2021 - 05/2016
2	Radiotherapy 01/2023 - 11/2020
2	Neoadjuvant Therapy 01/2018 - 02/2012
1	Molecular Targeted Therapy 10/2022
1	Investigational Therapies (Experimental Therapy) 04/2021
1	Immunotherapy 11/2020
1	Combined Modality Therapy 10/2020